diltiazem has been researched along with Diabetic Glomerulosclerosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ainwan, P; Krairittichai, U; Mahannopkul, R; Sarinnapakorn, V | 1 |
| Blanco, S; Casas, I; López, D; Penin, R; Romero, R | 1 |
| Edwards, C; Gladding, P; Pilmore, H | 1 |
| Bayle, F; Bessard, G; Contamin, C; Hardy, G; Serre-Debeauvais, F; Stanke-Labesque, F; Zaoui, P | 1 |
| Blanco, S; Bonet, J; Casas, I; López, D; Romero, R | 1 |
| Sica, D | 1 |
| Carrera, MJ; Micaló, T; Montanya, E; Pérez-Maraver, M; Sahun, M; Soler, J; Vinzia, C | 1 |
| Reams, GP | 1 |
| Bakris, G; Brown, S; Gaber, L; Walton, C | 1 |
| Bakris, GL; Sadler, R; Slataper, R; Vicknair, N | 1 |
| Bakris, GL; Smith, A | 1 |
| Bakris, GL; Smith, AC; Toto, R | 1 |
| Bakris, GL; Demarie, BK | 1 |
2 review(s) available for diltiazem and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Calcium channel blockers and the kidney.
Topics: Black or African American; Calcium Channel Blockers; Diabetic Nephropathies; Dihydropyridines; Diltiazem; Humans; Hypertension; Kidney; Kidney Failure, Chronic; United States; Verapamil | 2004 |
Do calcium channel blockers have renal protective effects?
Topics: Aging; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Cyclosporine; Diabetic Nephropathies; Dihydropyridines; Diltiazem; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension, Renal; Kidney; Kidney Transplantation; Rats; Rats, Inbred SHR; Verapamil | 1994 |
6 trial(s) available for diltiazem and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Renal Protective Effects of Combination of Diltiazem and ACEI/ARB on the Progression of Diabetic Nephropathy: Randomized Controlled Trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Humans; Prospective Studies; Thailand | 2017 |
Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prospective Studies | 2005 |
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Topics: Albuminuria; Antihypertensive Agents; Atenolol; Diabetic Nephropathies; Diltiazem; Dipeptides; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Lisinopril; Middle Aged; Prospective Studies; Renal Circulation | 1993 |
Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
Topics: Aged; Albuminuria; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Cross-Over Studies; Diabetic Nephropathies; Diltiazem; Female; Humans; Male; Middle Aged; Nifedipine; Prospective Studies; Sodium, Dietary | 1996 |
Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy.
Topics: Adult; Aged; Calcium Channel Blockers; Diabetic Nephropathies; Diltiazem; Female; Humans; Kidney Glomerulus; Male; Middle Aged; Nifedipine; Proteinuria | 1998 |
Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.
Topics: Aged; Creatinine; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Female; Humans; Hypertension; Male; Metabolic Clearance Rate; Middle Aged; Nifedipine; Prospective Studies; Proteinuria | 1990 |
5 other study(ies) available for diltiazem and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Disease Models, Animal; Drug Therapy, Combination; Linear Models; Male; Obesity; Podocytes; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines | 2002 |
Potentially fatal interaction between diltiazem and statins.
Topics: Aged; Diabetic Nephropathies; Diltiazem; Drug Interactions; Fatal Outcome; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Rhabdomyolysis | 2004 |
Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report.
Topics: Adult; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diagnosis, Differential; Diltiazem; Drug Interactions; HIV Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Protease Inhibitors; Tacrolimus | 2004 |
ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; DNA, Complementary; Immunoenzyme Techniques; Male; Membrane Proteins; Microfilament Proteins; Obesity; Proteins; Quinapril; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrahydroisoquinolines | 2005 |
Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs.
Topics: Animals; Antihypertensive Agents; Diabetic Nephropathies; Diltiazem; Dogs; Drug Therapy, Combination; Fibrosis; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Lisinopril; Nephrectomy; Nephritis, Interstitial | 1994 |